In the United Kingdom, rates of the disease were highest for those born in December, while in Poland, rates were highest for those born in January.
The first-ever guideline from Endocrine Society on Addison's disease details specifics of diagnostic tests and glucocorticoid therapy.
Both high- and low-dose adrenocorticotropic hormone stimulation tests are adequate for including adrenal insufficiency as a diagnosis.
Many patients with adrenal insufficiency do not receive adequate education on steroid dose adjustment or have emergency glucocorticoid kits.
All patients using corticosteroid therapy are at risk for adrenal insufficiency, and clinicians should educate patients about this risk.
The etiology of Cushing's syndrome affects how long it takes for a patient to recover their adrenal function after surgery.
Adrenal insufficiency appears to impact patients differently and influences their beliefs about hydrocortisone replacement.
Critical illness alters adrenal glands and contributes to adrenal insufficiency in ICU patients.
Addison disease patients may not benefit from continuous subcutaneous hydrocortisone infusion.
Endocrinology Advisor Articles
- Gestational Diabetes Risk May Be Reduced With Probiotics
- Type 2 Diabetes Therapy Intensification: Part I: Insulin vs GLP-1 Agonists
- American Association of Clinical Endocrinologists 2017 Meeting Preview
- Driving Risk Assessment for Patients With Type 1 Diabetes
- Type 2 Diabetes Therapy Intensification: Part II: GLP-1 Agonist Adverse Effects and Fixed-Ratio Combinations
- Achieving Low HbA1c Levels Benefited Metformin Initiators
- Gestational Diabetes Incidence Did Not Decrease With Inositol Therapy
- Functional Hypothalamic Amenorrhea Diagnosis and Treatment Guidelines Released
- Anticholinergic Medications May Increase Dementia Risk in Diabetes
- Metabolic Syndrome Rates Differ by Race, Ethnicity in Women With Polycystic Ovary Syndrome